# Abbvie Ireland NL B.V. – FDA Inspection, Aug 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/abbvie-ireland-nl-bv/a89be99f-7bd4-47f7-b2b1-2622fe0dea97
Source feed: FDA_Inspections

> FDA inspection 1105474 of Abbvie Ireland NL B.V., August 29, 2019. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1105474
- Company Name: Abbvie Ireland NL B.V.
- Inspection Date: 2019-08-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1253298 - 2022-12-14](https://www.keypedia.com/records/fda_inspections/abbvie-ireland-nl-bv/ecd3cdcc-9f69-4553-b801-84bc390d600e)
- FDA Inspection 1124019 - 2020-02-28
- FDA Inspection 1000859 - 2017-01-20
- FDA Inspection 899864 - 2014-09-12
- FDA Inspection 717041 - 2011-03-24

## Related Officers

- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)

Company: https://www.keypedia.com/companies/abbvie-ireland-nl-bv/d0befdd3-e659-4b7f-8c3c-4bd81f8270f2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c